Adverse Events Following Immunization Report and Vaccine Effectiveness of Sinovac. An Interim Report

Simatupang, Abraham and Sirait, Robert Hotman and Siagian, Forman Erwin and Sitompul, Yunita R.M.B and Achmad, Luana N. and Nainggolan, Sudung (2021) Adverse Events Following Immunization Report and Vaccine Effectiveness of Sinovac. An Interim Report. Atlantis Press. pp. 251-256. ISSN 2468 5739

	Text AdverseEventsFollowingImmunization.pdf Download (1MB)
	Text (Hasil_Turnitin) HasilTurnitinAdverseEventsFollowingImmunizationReport.pdf Download (1MB)
	Text (Peer_Review _Achmad, Luana N.) PeerReviewAdverseEventsFollowingImmunizationReport.pdf Download (1MB)

Abstract

Vaccination is a prevention of transmission and spread and in order to establish herd immunity against the Covid�19 pandemic. Indonesia chose the Sinovac vaccine, which uses weakened viruses. The objective of the study was to measure the Adverse Events Following Immunization (AEFI) 24-72 hours post-vaccination and its effect at three months after vaccination. An online survey was distributed to 1574 subjects who received the first dose, and 530 respondents (response rate 33.6%) who answered the questionnaire were sent the form again for the second dose, and 249 subjects responded (response rate 46.9%). From the first dose: 322 female (60.9%), 207 male (39.1%). There were 22 respondents who had fever on the first day and only five respondents on the second day. In addition, 147 (27.8%) felt pain in the injection site, nausea 30 respondents (5.7%), vomiting six persons, bloating 35 respondents (6.6%), and diarrhea ten respondents (1.9%). Fifty-nine respondents who got mild adverse events did nothing to ease their adverse events, 18 respondents took self-medication, 15 respondents consulted the doctors in the vaccination site. Only one respondent went to the nearby hospital for further therapy. Results from the second dose: As many 249 respondents (131 female, 108 male) answered respondents. The AEFI’s pattern was quite the same as the first dose. Keywords: AEFI, Sinovac, Covid-19

Actions (login required)

View Item